Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro

ClinicalTrials.gov ID: NCT04254380

Public ClinicalTrials.gov record NCT04254380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multicenter, Phase 3 Study to Compare the Immunogenicity, Efficacy, and Safety of Gan & Lee Insulin Lispro Injection to Humalog in Adult Subjects With Type 1 Diabetes Mellitus (T1DM)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: • To compare the immunogenicity of Gan \& Lee Insulin Lispro Injection and EU-authorized Humalog following treatment in adult subjects with T1DM Secondary Objectives: * To evaluate the safety of Gan \& Lee Insulin Lispro Injection in comparison with that of EU authorized Humalog following treatment in adult subjects with T1DM * To evaluate the efficacy of Gan \& Lee Insulin Lispro Injection in comparison with that of EU authorized Humalog following treatment in adult subjects with T1DM

Study identification

NCT ID
NCT04254380
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Enrollment
Not listed

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 4, 2019 (Actual)
Primary completion
Jan 27, 2020 (Actual)
Completion
Jan 27, 2020 (Actual)
Last update posted
Feb 5, 2020

2019 – 2020

United States locations

U.S. sites
58
U.S. states
19
U.S. cities
55
Facility City State ZIP Site status
Advanced Research Center Anaheim California 92805 —
Valley Research Fresno California 93720 —
Angel City Research, Inc. Los Angeles California 90057 —
California Medical Research Association Northridge California 91324 —
Mills-Peninsula Health Services San Mateo California 94401 —
Care Access Research - Santa Clarita Santa Clarita California 91321 —
Metabolic Institute of America Tarzana California 91356 —
University of Colorado School of Medicine Aurora Colorado 80045 —
IMMUNOe International Research Centers - Longmont Longmont Colorado 80501 —
Chase Medical Research of Greater New Haven Hamden Connecticut 06517 —
The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312 —
M & O Clinical Research Fort Lauderdale Florida 33316 —
Sweet Hope Research Specialty Inc. Hialeah Florida 33016 —
Homestead Associates in Research Homestead Florida 33032 —
Med Research of Florida Miami Florida 33186 —
Suncoast Clinical Research - Pasco County New Port Richey Florida 34652 —
Florida Institute for Clinical Research, LLC Orlando Florida 32825 —
Ormond Beach Clinical Research Ormond Beach Florida 32174 —
Suncoast Clinical Research - Pinellas County Palm Harbor Florida 34684 —
Meridien Research - Spring Hill Spring Hill Florida 34609 —
Metabolic Research Institute West Palm Beach Florida 33401 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
IACT Health - Columbus Regional Medical Group Endocrine Consultants - Columbus Columbus Georgia 31904 —
IACT Health - Columbus Regional Medical Group Endocrine Consultants Newnan Georgia 30265 —
Endocrine Research Solutions Roswell Georgia 30076 —
Cedar Crosse Research Center Chicago Illinois 60607 —
Midwest CRC Crystal Lake Illinois 60012 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503 —
Bay West Endocrinology Associates Baltimore Maryland 21204 —
BTC Network - Capital Diabetes and Endocrine Associates - Camp Springs Camp Springs Maryland 20746 —
Endocrine & Metabolic Consultants Rockville Maryland 20852 —
Quality Clinical Research Omaha Nebraska 68134 —
Palm Research Center Las Vegas Nevada 89148 —
BTC Network - Garden State Endocrinology - Brick Brick New Jersey 08723 —
The Endocrine Group, LLP Albany New York 12206 —
North Shore Diabetes and Endocrine Associates New Hyde Park New York 11042 —
University Physicians Group Staten Island New York 10301 —
PharmQuest Greensboro North Carolina 27408 —
Physicians East - Greenville Greenville North Carolina 27834 —
Carteret Medical Group - Morehead City Morehead City North Carolina 28557 —
Endocrinology Research Associates Columbus Ohio 43201 —
Your Diabetes Endocrine Nutrition Group, Inc. Mentor Ohio 44060 —
Intend Research Norman Oklahoma 73069 —
Lynn Institute of Stillwater Stillwater Oklahoma 73111 —
Care Access Research - Warwick Warwick Rhode Island 02886 —
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411 —
Amarillo Medical Specialists Amarillo Texas 79106 —
Austin Regional Clinic Austin Texas 78704 —
Texas Diabetes & Endocrinology - Central Austin Austin Texas 78731 —
Research Institute of Dallas Dallas Texas 75231 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
El Paso Medical Research Institute El Paso Texas 79935 —
Pioneer Research Solutions Houston Texas 77099 —
Austin Regional Clinic - Kelly Lane Pflugerville Texas 78660 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Northeast Clinical Research of San Antonio Schertz Texas 78154 —
Crossroads Clinical Research Victoria Texas 77901 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04254380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04254380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →